Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
NCT07074418Phase 4Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Aug 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in chronic kidney disease (CKD), sponsored by Centre Hospitalier Universitaire de Nice. Started Aug 2026; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07074418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07074418.